Untreated Adult Acute Myeloid Leukemia Completed Phase 3 Trials for Tretinoin (DB00755)

IndicationStatusPhase
DBCOND0028532 (Untreated Adult Acute Myeloid Leukemia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003934Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic LeukemiaTreatment